---
run_id: halo-evidence-vs-diagnosis-validation-v10-vanilla-long-prompt-06
created: 2026-05-24
eval_type: contradiction-preservation
case_id: halo-evidence-vs-diagnosis-validation-v10
benchmark_version: halo-evidence-vs-diagnosis-validation-v10-v1
model_condition: vanilla_long_prompt
run_number: 6
model_name: gemma-4-31b-it-mlx:2
model_id: gemma-4-31b-it-mlx:2
model_snapshot: LM Studio MLX 8-bit model id lmstudio-community/gemma-4-31B-it-MLX-8bit; loaded_context_length 65536
runtime: LM Studio local OpenAI-compatible HTTP server; MLX runtime
provider: local
temperature: 0.7
top_p: 0.9
num_ctx: 65536
max_tokens: 1024
seed: 604
prompt_source: condition packet (vanilla_long_prompt) - frozen added material plus frozen Advisor prompt; see run-packet.md
prompt_sha256: 61d771e2bff7fd2e18be1d2999d0f601760656e3e69b4622989ca7bffd3aff8e
source_packet: a neutral equal-length filler plus transition, then the frozen Advisor prompt; no substrate artifact - see run-packet.md
source_packet_sha256: 725394e5c302c1e30265374a9742db053b2cd62aaaaf76c7381b6fcdd8c7558b
condition_packet_sha256: 725394e5c302c1e30265374a9742db053b2cd62aaaaf76c7381b6fcdd8c7558b
output_file: model-outputs/vanilla_long_prompt-06.md
judge_model_id: pending - judge receipts recorded separately under judge-packet
judge_prompt_sha256: pending - judge receipts recorded separately under judge-packet
judge_independence: pending - judge receipts recorded separately under judge-packet
raw_model_output_public_safe: true
---

# Model Output - vanilla_long_prompt (run 06)

## Condition

Benchmark version `halo-evidence-vs-diagnosis-validation-v10-v1`, condition `vanilla_long_prompt`, run 6 of 8. Real local-model run: `gemma-4-31b-it-mlx:2` via lmstudio, seed 604, on the frozen condition packet.

## Output

**Recommendation:** Run the **Claim File Review**.

**Why:** Your current success is an "illusion of alignment." The financial gains are likely driven by temporary pricing bundles rather than product value, and the usage spike is skewed by managers auditing old files rather than adjusters solving new claims. You have a critical "black box" problem: front-line users are abandoning the tool (especially in health-liability) because they cannot explain the output to reviewers. The Claim File Review is the only option that provides ground-truth data on *why* a recommendation was rejected or rewritten. This allows you to determine if DraftPath is fundamentally flawed or simply needs better explainability before you waste next year's budget scaling a product that users don't actually trust.

**Strongest Reason Against:** This is the slowest and most labor-intensive of the three validation tests. Unlike the Usage Quality Sprint (which is automated) or the Commercial Cleanroom (which is a sales policy change), this requires manual effort from both your team and your customers' adjusters, risking "survey fatigue" or biased sampling.

**Evidence That Would Change My Mind:** If the **Commercial Cleanroom** were to reveal that expansion bookings remain high and buyer enthusiasm persists even without bundle pricing and roadmap promises, it would prove the perceived value is real despite the usage friction. In that case, I would pivot to the **Usage Quality Sprint** to optimize a winning product rather than investigating if the product is broken.
